J4
• 化学 • Previous Articles Next Articles
ZHAO Shuang1, XU Zhibing1, E Chenguang1, LI Zhuo1, WANG Ensi1,2
Received:
Revised:
Online:
Published:
Contact:
Abstract: Repaglinide (a new antidiabetic medicine), (S)(+)-2-ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbo nylmethyl]benzoic acid, was synthesized by means of Ph3P catalyzed condensation and LDA/DMPU catalyzed carboxylation as pivotal steps from the starting materials 4-methylsalicylic acid and 2-chlorobenzonitrile. Repaglinide was synthesized in a total yield of 10.5%. The structures of the targetmolecule and the key intermediates were confirmed by IR, 1H NMR,13C NMR, elemental analysis, specific rotation and MS techniques.
Key words: repaglinide, chemical resolution technique, optical r otation, antidiabetic medicine
CLC Number:
ZHAO Shuang, XU Zhibing, E Chenguang, LI Zhuo, WANG Ensi,. Synthesis of Antidiabetic Medicine Repaglinide[J].J4, 2008, 46(03): 556-559.
0 / / Recommend
Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks
URL: http://xuebao.jlu.edu.cn/lxb/EN/
http://xuebao.jlu.edu.cn/lxb/EN/Y2008/V46/I03/556
Cited